Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perianal infiltration with ropivacaine during RAFAELO radiofrequency hemorrhoid thermodestruction
2021-006904-34Phase 4Active
- Sponsor
- CHD Vendée
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in hemorrhoid (2 arms), sponsored by CHD Vendée. Primary endpoint: Visual Analogue Scale pain score at 6 hours post-operation. Started Apr 2022; status: active.
02
Drugs
ropivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on 2021-006904-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006904-34.